Northwire Canada EditionWednesday, July 15, 2026
Northwire
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Financings

WELL Health Provides Corporate Update on Capital Allocation Program Including Expanded Credit Facility and the Strategic Acquisition of a Leading E-Consult Platform

WELL · Price

Executive Summary

  • WELL Health Technologies completed a $33 million cash acquisition of E‑Consult Canada LP (61% stake) and eight primary‑care clinics in Alberta, adding an e‑consult platform and ~30 providers.
  • The company upsized its senior secured credit facility to $400 million (plus a $100 million uncommitted accordion) with lenders led by RBC, JPMorgan, and TD, extending maturity to 2030 and leaving >$195 million of unused capacity.
  • In 2025 WELL executed 20 clinic acquisitions (including three absorptions), deploying ~$77 million—over 400% more capital than in 2024—and now has ~ $245 million of clinical revenue under LOI or advanced‑stage targets.

Key Details

  • Acquisition Terms:
  • 100% ownership of eight Alberta clinics (closed Dec 1 2025).
  • 61% equity interest in E‑Consult Canada LP for approximately $33 M cash (closed Feb 1 2026).
  • Pro forma annual revenue contribution from the combined assets: ≈ $45 M, with gross margins ~48% and Adjusted EBITDA margin >20%.

  • Credit Facility:

  • Total committed capacity $400 M (up from prior $200 M).
  • Additional $100 M uncommitted accordion facility.
  • Extended term to January 2030; leverage expected < 3.0× as of Dec 31 2025 and post‑acquisition.
  • Remaining available capacity > $195 M.

  • Clinic Acquisition Activity (2025):

  • Completed 20 clinic transactions (including three absorptions), double the prior year’s count.
  • Capital deployed ≈ $77 M, a >400% increase versus 2024.

  • Pipeline & Future Growth:

  • Approximately $245 M of clinical revenue under advanced‑stage negotiations or signed LOIs for future acquisitions.
  • Expanded e‑consult capability supports over 100 providers and positions WELL to roll out services to additional provinces/territories and Indigenous communities.

Notable Quotes

  • “The expansion and extension of our senior secured credit facility significantly enhances our financial flexibility… we’ve acquired a scalable, technology‑enabled healthcare e‑consult capability…” – Hamed Shahbazi, Founder & CEO, WELL Health Technologies.
  • “The majority of our clinics have now completed their initial stage of digitization… we are already seeing the positive effects of our digitization work along with strong patient satisfaction.” – Dr. Michael Frankel, Chief Medical Officer & President, Canadian Clinics.
Read the original news release →

More from WELL HEALTH TECHNOLOGIES CORP. J